Literature DB >> 23607785

Structures and free energy landscapes of the A53T mutant-type α-synuclein protein and impact of A53T mutation on the structures of the wild-type α-synuclein protein with dynamics.

Orkid Coskuner1, Olivia Wise-Scira.   

Abstract

The A53T genetic missense mutation of the wild-type α-synuclein (αS) protein was initially identified in Greek and Italian families with familial Parkinson's disease. Detailed understanding of the structures and the changes induced in the wild-type αS structure by the A53T mutation, as well as establishing the direct relationships between the rapid conformational changes and free energy landscapes of these intrinsically disordered fibrillogenic proteins, helps to enhance our fundamental knowledge and to gain insights into the pathogenic mechanism of Parkinson's disease. We employed extensive parallel tempering molecular dynamics simulations along with thermodynamic calculations to determine the secondary and tertiary structural properties as well as the conformational free energy surfaces of the wild-type and A53T mutant-type αS proteins in an aqueous solution medium using both implicit and explicit water models. The confined aqueous volume effect in the simulations of disordered proteins using an explicit model for water is addressed for a model disordered protein. We also assessed the stabilities of the residual secondary structure component interconversions in αS based on free energy calculations at the atomic level with dynamics using our recently developed theoretical strategy. To the best of our knowledge, this study presents the first detailed comparison of the structural properties linked directly to the conformational free energy landscapes of the monomeric wild-type and A53T mutant-type α-synuclein proteins in an aqueous solution environment. Results demonstrate that the β-sheet structure is significantly more altered than the helical structure upon A53T mutation of the monomeric wild-type αS protein in aqueous solution. The β-sheet content close to the mutation site in the N-terminal region is more abundant while the non-amyloid-β component (NAC) and C-terminal regions show a decrease in β-sheet abundance upon A53T mutation. Obtained results utilizing our new theoretical strategy show that the residual secondary structure conversion stabilities resulting in α-helix formation are not significantly affected by the mutation. Interestingly, the residual secondary structure conversion stabilities show that secondary structure conversions resulting in β-sheet formation are influenced by the A53T mutation and the most stable residual transition yielding β-sheet occurs directly from the coil structure. Long-range interactions detected between the NAC region and the N- or C-terminal regions of the wild-type αS disappear upon A53T mutation. The A53T mutant-type αS structures are thermodynamically more stable than those of the wild-type αS protein structures in aqueous solution. Overall, the higher propensity of the A53T mutant-type αS protein to aggregate in comparison to the wild-type αS protein is related to the increased β-sheet formation and lack of strong intramolecular long-range interactions in the N-terminal region in comparison to its wild-type form. The specific residual secondary structure component stabilities reported herein provide information helpful for designing and synthesizing small organic molecules that can block the β-sheet forming residues, which are reactive toward aggregation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23607785      PMCID: PMC3715894          DOI: 10.1021/cn400041j

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  63 in total

1.  Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Authors:  R Krüger; W Kuhn; T Müller; D Woitalla; M Graeber; S Kösel; H Przuntek; J T Epplen; L Schöls; O Riess
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

2.  Alpha-synuclein in Lewy bodies.

Authors:  M G Spillantini; M L Schmidt; V M Lee; J Q Trojanowski; R Jakes; M Goedert
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

3.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

4.  Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features.

Authors:  W Kabsch; C Sander
Journal:  Biopolymers       Date:  1983-12       Impact factor: 2.505

5.  Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes.

Authors:  W S Davidson; A Jonas; D F Clayton; J M George
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

6.  Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

Authors:  K A Conway; J D Harper; P T Lansbury
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

Review 7.  The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease.

Authors:  D F Clayton; J M George
Journal:  Trends Neurosci       Date:  1998-06       Impact factor: 13.837

8.  Curvature dynamics of alpha-synuclein familial Parkinson disease mutants: molecular simulations of the micelle- and bilayer-bound forms.

Authors:  Jason D Perlmutter; Anthony R Braun; Jonathan N Sachs
Journal:  J Biol Chem       Date:  2009-01-05       Impact factor: 5.157

9.  Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine.

Authors:  Charbel E-H Moussa; Christophe Wersinger; York Tomita; Anita Sidhu
Journal:  Biochemistry       Date:  2004-05-11       Impact factor: 3.162

10.  Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.

Authors:  P H Jensen; M S Nielsen; R Jakes; C G Dotti; M Goedert
Journal:  J Biol Chem       Date:  1998-10-09       Impact factor: 5.157

View more
  27 in total

Review 1.  Dynamic structural flexibility of α-synuclein.

Authors:  Danielle E Mor; Scott E Ugras; Malcolm J Daniels; Harry Ischiropoulos
Journal:  Neurobiol Dis       Date:  2015-12-31       Impact factor: 5.996

2.  Asymmetric Synthesis of Griffipavixanthone Employing a Chiral Phosphoric Acid-Catalyzed Cycloaddition.

Authors:  Michael J Smith; Kyle D Reichl; Randolph A Escobar; Thomas J Heavey; David F Coker; Scott E Schaus; John A Porco
Journal:  J Am Chem Soc       Date:  2018-12-26       Impact factor: 15.419

3.  Molecular determinants of α-synuclein mutants' oligomerization and membrane interactions.

Authors:  Igor F Tsigelny; Yuriy Sharikov; Valentina L Kouznetsova; Jerry P Greenberg; Wolf Wrasidlo; Cassia Overk; Tania Gonzalez; Margarita Trejo; Brian Spencer; Kori Kosberg; Eliezer Masliah
Journal:  ACS Chem Neurosci       Date:  2015-01-21       Impact factor: 4.418

4.  Familial Parkinson disease-associated mutations alter the site-specific microenvironment and dynamics of α-synuclein.

Authors:  Shruti Sahay; Dhiman Ghosh; Saumya Dwivedi; Arunagiri Anoop; Ganesh Maruti Mohite; Mamata Kombrabail; Guruswamy Krishnamoorthy; Samir K Maji
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

5.  Synaptic vesicle mimics affect the aggregation of wild-type and A53T α-synuclein variants differently albeit similar membrane affinity.

Authors:  Sandra Rocha; Ranjeet Kumar; Istvan Horvath; Pernilla Wittung-Stafshede
Journal:  Protein Eng Des Sel       Date:  2019-12-13       Impact factor: 1.650

Review 6.  Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.

Authors:  Orkid Coskuner-Weber; Vladimir N Uversky
Journal:  Int J Mol Sci       Date:  2018-01-24       Impact factor: 5.923

7.  Arginine and disordered amyloid-β peptide structures: molecular level insights into the toxicity in Alzheimer's disease.

Authors:  Orkid Coskuner; Olivia Wise-Scira
Journal:  ACS Chem Neurosci       Date:  2013-10-08       Impact factor: 4.418

8.  Effects of Mutations on the Reconfiguration Rate of α-Synuclein.

Authors:  Srabasti Acharya; Shreya Saha; Basir Ahmad; Lisa J Lapidus
Journal:  J Phys Chem B       Date:  2015-12-04       Impact factor: 2.991

9.  Divalent copper ion bound amyloid-β(40) and amyloid-β(42) alloforms are less preferred than divalent zinc ion bound amyloid-β(40) and amyloid-β(42) alloforms.

Authors:  Orkid Coskuner
Journal:  J Biol Inorg Chem       Date:  2016-09-22       Impact factor: 3.358

Review 10.  Computational approaches to understanding protein aggregation in neurodegeneration.

Authors:  Rachel L Redler; David Shirvanyants; Onur Dagliyan; Feng Ding; Doo Nam Kim; Pradeep Kota; Elizabeth A Proctor; Srinivas Ramachandran; Arpit Tandon; Nikolay V Dokholyan
Journal:  J Mol Cell Biol       Date:  2014-03-11       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.